Sofwave Medical

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Sofwave Medical sits in the top decile of US sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count).

12 total trials 2 currently recruiting 8 completed top decile by trial count

Sofwave Medical: 12 sponsored US clinical trials, 2 recruiting.

Sofwave Medical sponsors 12 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 8 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Skin Lax and Muscle Strength, with 1 trials.

Top-decile sponsor footprint

Sofwave Medical ranks in the top decile of sponsors by registered trial count (#1,137 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 3 1

What is open in the Sofwave Medical pipeline

2 recruiting of 12 indexed (17% open); 8 completed (67%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Skin Lax and Muscle Strength (1 trial), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Sofwave Medical: open-pipeline peers nationwide

Peers matched on 12 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Sofwave Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 468101214 0%5%10%15%20% Total trials Recruiting share Sofwave MedicalAlachua Government ServicesAllergy TherapeuticsAmpio Pharmaceuticals.AngiodynamicsAdageneAgendiaAkamis BioAnthos Therapeutics
Sofwave Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Sofwave Medical sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 12 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Sofwave Medical page

12 registered trials is a research-attention snapshot, not an endorsement of Sofwave Medical or any single study.

  • 2 of Sofwave Medical's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Skin Lax and Muscle Strength is the condition Sofwave Medical studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Skin Lax and Muscle Strength trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Sofwave Medical pipeline card: 12 registered trials from official public datasets.Report a data error.